| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |